Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Larimar Therapeutics Inc (LRMR)
Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 532,141
  • Shares Outstanding, K 43,906
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,360 K
  • 60-Month Beta 0.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.62
Trade LRMR with:

Options Overview Details

View History
  • Implied Volatility 120.34% ( -0.84%)
  • Historical Volatility 128.18%
  • IV Percentile 75%
  • IV Rank 42.49%
  • IV High 280.65% on 02/09/24
  • IV Low 1.89% on 11/14/23
  • Put/Call Vol Ratio 9.85
  • Today's Volume 1,128
  • Volume Avg (30-Day) 1,868
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 25,271
  • Open Int (30-Day) 11,107

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -0.28
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.25 +185.18%
on 01/24/24
13.68 -11.40%
on 02/15/24
+7.62 (+169.33%)
since 01/23/24
3-Month
3.19 +279.94%
on 11/29/23
13.68 -11.40%
on 02/15/24
+8.80 (+265.06%)
since 11/22/23
52-Week
2.18 +455.96%
on 11/10/23
13.68 -11.40%
on 02/15/24
+5.88 (+94.23%)
since 02/23/23

Most Recent Stories

More News
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 223.32 (+0.38%)
XBI : 94.75 (+0.64%)
XLK : 205.29 (-0.23%)
OCUL : 9.86 (+1.65%)
LRMR : 12.12 (+3.59%)
Larimar: Q3 Earnings Snapshot

Larimar: Q3 Earnings Snapshot

LRMR : 12.12 (+3.59%)
Larimar: Q2 Earnings Snapshot

Larimar: Q2 Earnings Snapshot

LRMR : 12.12 (+3.59%)
Larimar: Q1 Earnings Snapshot

Larimar: Q1 Earnings Snapshot

LRMR : 12.12 (+3.59%)
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat

Nektar's (NKTR) Q1 loss is narrower than expected while revenues beat estimates.

LLY : 769.54 (-0.01%)
NKTR : 0.6824 (+3.24%)
ITRM : 1.2700 (-5.93%)
LRMR : 12.12 (+3.59%)
Larimar (LRMR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Larimar (LRMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LRMR : 12.12 (+3.59%)
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates

Thervance's (TBPH) first-quarter 2023 loss wider than expected. Revenues decline year over year and also miss estimates.

TBPH : 8.98 (+3.52%)
ITRM : 1.2700 (-5.93%)
LRMR : 12.12 (+3.59%)
VTRS : 13.53 (+1.27%)
New Strong Buy Stocks for May 9th

SBGI, AQST, PLTK, GTX and LRMR have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2023

SBGI : 14.59 (-1.29%)
AQST : 2.57 (-2.28%)
GTX : 9.42 (+1.29%)
LRMR : 12.12 (+3.59%)
PLTK : 7.20 (-0.69%)
New Strong Buy Stocks for April 19th

SIGA, RYI, LRMR, VRTV and PLL have been added to the Zacks Rank #1 (Strong Buy) List on April 19, 2023.

PLL : 12.34 (-10.71%)
SIGA : 5.32 (+3.50%)
VRTV : 169.99 (+0.02%)
RYI : 32.82 (+1.89%)
LRMR : 12.12 (+3.59%)
Here's Why You May Add Nektar (NKTR) Stock to Your Portfolio

Here we discuss some reasons why investing in Nektar Therapeutics (NKTR) stock now is a good idea despite its several pipeline setbacks.

LLY : 769.54 (-0.01%)
NKTR : 0.6824 (+3.24%)
LRMR : 12.12 (+3.59%)
SRZN : 12.47 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.

See More

Key Turning Points

3rd Resistance Point 13.25
2nd Resistance Point 12.87
1st Resistance Point 12.50
Last Price 12.12
1st Support Level 11.75
2nd Support Level 11.37
3rd Support Level 11.00

See More

52-Week High 13.68
Last Price 12.12
Fibonacci 61.8% 9.29
Fibonacci 50% 7.93
Fibonacci 38.2% 6.57
52-Week Low 2.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar